EARNING RECAP

Twitter Inc

#TWTR 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 adjusted 5c est. 19c $841.4M est. $829.07M +8.92% ($41.52 closing price) $42.33 $40 sees Q3 revenue $815M- $875M est. $869.31M; sees FY19 GAAP operating expenses up 20% y/y
Q1 adjusted 9c est. 15c $787M est. $775M +15.64% ($39.77 closing price) $40.53 $36.91 sees Q2 revenue $770M-$830M est. $819.3M operating income $35M-$70M; FY19 capex $550M-$600M
#TWTR 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 31c est. 25c $909M est. $869.5M -9.84% ($30.80 closing price) $31.73 $30.31 sees Q1 revenue $715M-$775M est. $762.43M; says revenue up 24% YoY; guides FY19 CAPEX at $550M- $600M
Q3 adjusted EPS 21c vs 14c $758m vs $702.57m +15.47% ($31.80 closing) $33.67 $30.76 monthly active users 326M in Q3
Q2 17c est. 17c $711M est. $696.23M -20.54% ($34.12 closing) $37.47 $33.90 reports 335M average MAUs for Q2;
Q1 16c est. 16c $664.9M est.$605.26M -1.38% ($30.05 closing) $32.70 $28.14 Q1 DAU grew 10% YoY; revenue grew 21% YoY; MAU up 3%YoY; sees Q2 EBITDA $245-$265M & EBITDA margin37%-38%
#TWTR 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 19c est. 14c $731.6M est. $686.06M +12.56% ($30.29 closing) $35.00 $26.89 Q4 MAUs 330M up 4% YoY/ U.S. MAUs 68M
Q3 10c vs. 7c $590M vs. $586.7M +18.49% ($20.31 closing) $20.63 $18.90 sees Q4 EBITDA margin at $220M-$240M; 35%&36%; denotes
Q2 8c vs 5c $573.9M vs $537.2M -14.13% ($16.84 closing) $17.60 $16.50 -10.35% at $17.58. Sees ‘great momentum’ with ads coming out of front
Q1 11c Vs 1c $548.25m vs $511.90M +7.91% ($15.82 closing) $16.48 $15.76 Average monthly users up 6% to 328M

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.